ERBB2 and breast carcinoma: For instance, BsAbs that bind to both CD3 on T cells and human epidermal growth factor receptor 2 (HER2) on breast cancer cells have been developed to redirect T cells to tumor cells, promoting tumor cell destruction (Alaluf et al. 2024; Junttila et al. 2014).